Loading organizations...
Loading organizations...
Hongxin Investment Management Center: Investment firm managing portfolios in China, focusing on biotechnology and semiconductors.
Hongxin Investment Management Center is an investment firm based in Hainan, China, specializing in managing investment portfolios and providing comprehensive investment management services. Operating as a limited partnership, the firm primarily deploys capital within the People's Republic of China, demonstrating strategic connections to the biotechnology and semiconductor sectors through its various portfolio relationships. While specific financial metrics like assets under management or employee figures are not publicly available, the firm leverages a network that includes several distinguished individuals. These include Dr. Zhou, a founder with over three decades of experience in virology and immunology, alongside Bernard Roizman, Thomas Eugene Shenk, and Richard James Whitley, who are identified as founding members of associated entities within its ecosystem. Hongxin Investment Management Center was established in 2016 by Dr. Zhou.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 5, 2026 | MetaSilicon | $43.2M Series A | Chengdu High-tech Ceyuan Capital, FAW Group, Wuxi Capital | China Securities, Futian Investment Holdings, GRC SinoGreen Fund, Huatian Technology, Innovation Works, Yihe Capital, Zhishou Investment |